Published in J Clin Invest on June 01, 1996
Impaired physiological responses to chronic hypoxia in mice partially deficient for hypoxia-inducible factor 1alpha. J Clin Invest (1999) 4.00
Pathogenic mechanisms of pulmonary arterial hypertension. J Mol Cell Cardiol (2007) 1.85
Pulmonary prostacyclin synthase overexpression in transgenic mice protects against development of hypoxic pulmonary hypertension. J Clin Invest (1999) 1.59
Inhibition of soluble epoxide hydrolase enhances the anti-inflammatory effects of aspirin and 5-lipoxygenase activation protein inhibitor in a murine model. Biochem Pharmacol (2009) 1.49
Hypoxia-induced pulmonary vascular remodeling: a model for what human disease? J Clin Invest (2000) 1.39
Inflammation and immunity in the pathogenesis of pulmonary arterial hypertension. Circ Res (2014) 1.38
A brief overview of mouse models of pulmonary arterial hypertension: problems and prospects. Am J Physiol Lung Cell Mol Physiol (2012) 1.18
Blocking macrophage leukotriene b4 prevents endothelial injury and reverses pulmonary hypertension. Sci Transl Med (2013) 1.05
Expression of 5-lipoxygenase in pulmonary artery endothelial cells. Biochem J (2002) 0.99
Placenta growth factor-induced early growth response 1 (Egr-1) regulates hypoxia-inducible factor-1alpha (HIF-1alpha) in endothelial cells. J Biol Chem (2010) 0.96
Cyclooxygenase-2 inhibition and hypoxia-induced pulmonary hypertension: effects on pulmonary vascular remodeling and contractility. Trends Cardiovasc Med (2009) 0.92
Genetically manipulated mouse models of lung disease: potential and pitfalls. Am J Physiol Lung Cell Mol Physiol (2011) 0.90
SMAD1 deficiency in either endothelial or smooth muscle cells can predispose mice to pulmonary hypertension. Hypertension (2013) 0.88
Chronic allergic inflammation causes vascular remodeling and pulmonary hypertension in BMPR2 hypomorph and wild-type mice. PLoS One (2012) 0.85
Antenatal maternal long-term hypoxia: acclimatization responses with altered gene expression in ovine fetal carotid arteries. PLoS One (2013) 0.85
Analysis of a nucleotide-binding site of 5-lipoxygenase by affinity labelling: binding characteristics and amino acid sequences. Biochem J (2000) 0.85
Increased eicosanoid levels in the Sugen/chronic hypoxia model of severe pulmonary hypertension. PLoS One (2015) 0.82
Chronic hypoxia promotes pulmonary artery endothelial cell proliferation through H2O2-induced 5-lipoxygenase. PLoS One (2014) 0.81
Genomic approaches to research in pulmonary hypertension. Respir Res (2001) 0.81
Characterization of a murine model of monocrotaline pyrrole-induced acute lung injury. BMC Pulm Med (2008) 0.81
Endothelial GATA-6 deficiency promotes pulmonary arterial hypertension. Am J Pathol (2013) 0.81
EETs Attenuate Ox-LDL-Induced LTB4 Production and Activity by Inhibiting p38 MAPK Phosphorylation and 5-LO/BLT1 Receptor Expression in Rat Pulmonary Arterial Endothelial Cells. PLoS One (2015) 0.81
Leukotrienes in pulmonary arterial hypertension. Immunol Res (2014) 0.79
Mechanisms underlying increased reactivity of pulmonary arteries contralateral to a localized high-flow anastomosis. J Thorac Cardiovasc Surg (2010) 0.78
Role of oxidized lipids in pulmonary arterial hypertension. Pulm Circ (2016) 0.77
ALOX5 is associated with tuberculosis in a subset of the pediatric population of North China. Genet Test Mol Biomarkers (2013) 0.75
Role of vascular endothelial growth factor signaling in Schistosoma-induced experimental pulmonary hypertension. Pulm Circ (2014) 0.75
Pulmonary vascular disease related to hemodynamic stress in the pulmonary circulation. Compr Physiol (2011) 0.75
Survival in patients with primary pulmonary hypertension. Results from a national prospective registry. Ann Intern Med (1991) 13.21
Exuberant endothelial cell growth and elements of inflammation are present in plexiform lesions of pulmonary hypertension. Am J Pathol (1994) 3.83
Hypoxia-mediated induction of endothelial cell interleukin-1 alpha. An autocrine mechanism promoting expression of leukocyte adhesion molecules on the vessel surface. J Clin Invest (1992) 2.34
Increased gene expression for VEGF and the VEGF receptors KDR/Flk and Flt in lungs exposed to acute or to chronic hypoxia. Modulation of gene expression by nitric oxide. J Clin Invest (1995) 2.30
Direct role for potassium channel inhibition in hypoxic pulmonary vasoconstriction. Am J Physiol (1992) 2.24
Hypoxic induction of interleukin-8 gene expression in human endothelial cells. J Clin Invest (1994) 2.09
The mechanism of acute hypoxic pulmonary vasoconstriction: the tale of two channels. FASEB J (1995) 1.87
Inhibition of hypoxic pulmonary vasoconstriction by calcium antagonists in isolated rat lungs. Circ Res (1976) 1.76
5-Lipoxygenase. Annu Rev Biochem (1994) 1.73
Hypoxia reduces potassium currents in cultured rat pulmonary but not mesenteric arterial myocytes. Am J Physiol (1993) 1.67
Altered inflammatory responses in leukotriene-deficient mice. Proc Natl Acad Sci U S A (1994) 1.59
Agarose infiltration improves morphology of cryostat sections of lung. Lab Invest (1994) 1.51
Interleukin-1 receptor antagonist treatment reduces pulmonary hypertension generated in rats by monocrotaline. Am J Respir Cell Mol Biol (1994) 1.18
Endothelial cell leukotriene C4 synthesis results from intercellular transfer of leukotriene A4 synthesized by polymorphonuclear leukocytes. J Biol Chem (1986) 1.13
PAF antagonists inhibit pulmonary vascular remodeling induced by hypobaric hypoxia in rats. J Appl Physiol (1985) (1992) 1.10
Alveolar inflammation and arachidonate metabolism in monocrotaline-induced pulmonary hypertension. Am J Physiol (1985) 1.06
Analysis of 6-keto PGF1 alpha, 5-HETE, and LTC4 in rat lung: comparison of GM/MS, RIA, and EIA. Prostaglandins (1986) 1.03
Membrane association of active 5-lipoxygenase in resting cells. Evidence for novel regulation of the enzyme in the rat alveolar macrophage. J Biol Chem (1992) 1.03
Acute hypoxia increases cytosolic calcium in fetal pulmonary artery smooth muscle cells. Am J Physiol (1993) 1.01
Native and mutant 5-lipoxygenase expression in a baculovirus/insect cell system. Proc Natl Acad Sci U S A (1989) 0.99
5-Lipoxygenase contains a functional Src homology 3-binding motif that interacts with the Src homology 3 domain of Grb2 and cytoskeletal proteins. J Biol Chem (1994) 0.98
A23187-induced translocation of 5-lipoxygenase in osteosarcoma cells. J Cell Biol (1992) 0.96
Nitric oxide-related vasoconstriction in lungs perfused with red cell lysate. FASEB J (1995) 0.87
Differential expression of arachidonate 5-lipoxygenase transcripts in human brain tumors: evidence for the expression of a multitranscript family. Proc Natl Acad Sci U S A (1992) 0.86
Polymorphonuclear leukocytes induced vasoconstriction in isolated canine coronary arteries. Circ Res (1990) 0.85
Diethylcarbamazine inhibits acute and chronic hypoxic pulmonary hypertension in awake rats. Am Rev Respir Dis (1985) 0.84
Formation of sulphidopeptide-leukotrienes by cell-cell interaction causes coronary vasoconstriction in isolated, cell-perfused heart of rabbit. Br J Pharmacol (1993) 0.84
Role of peptidoleukotrieens in hypoxic pulmonary vasoconstriction in rats. Am J Physiol (1990) 0.81
Role of membrane lipids in the control of normal vascular tone. Am Rev Respir Dis (1987) 0.81
Modification of the lipoxygenase pathway of arachidonic acid metabolism. Adv Prostaglandin Thromboxane Leukot Res (1990) 0.79
The role of leukotriene A4 hydrolase in cells and tissues lacking 5-lipoxygenase. Adv Exp Med Biol (1991) 0.78
Arachidonate 5-lipoxygenase of porcine leukocytes studied by enzyme immunoassay using monoclonal antibodies. J Biol Chem (1987) 0.78
Brca1 controls homology-directed DNA repair. Mol Cell (1999) 7.82
An animal model for cystic fibrosis made by gene targeting. Science (1992) 5.75
Altered cytokine production in mice lacking P2X(7) receptors. J Biol Chem (2001) 5.74
Inhibition of VEGF receptors causes lung cell apoptosis and emphysema. J Clin Invest (2000) 5.26
Mice with reduced NMDA receptor expression display behaviors related to schizophrenia. Cell (1999) 4.93
The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity. Proc Natl Acad Sci U S A (2001) 4.58
The breast cancer susceptibility gene BRCA1 is required for subnuclear assembly of Rad51 and survival following treatment with the DNA cross-linking agent cisplatin. J Biol Chem (2000) 4.49
Cystic fibrosis heterozygote resistance to cholera toxin in the cystic fibrosis mouse model. Science (1994) 3.97
Endothelial cell death and decreased expression of vascular endothelial growth factor and vascular endothelial growth factor receptor 2 in emphysema. Am J Respir Crit Care Med (2001) 3.92
Susceptibility of beta 2-microglobulin-deficient mice to Trypanosoma cruzi infection. Nature (1992) 3.50
Inhibition of the VEGF receptor 2 combined with chronic hypoxia causes cell death-dependent pulmonary endothelial cell proliferation and severe pulmonary hypertension. FASEB J (2001) 3.20
Brca1 deficiency results in early embryonic lethality characterized by neuroepithelial abnormalities. Nat Genet (1996) 2.99
LCMV-specific, class II-restricted cytotoxic T cells in beta 2-microglobulin-deficient mice. Science (1992) 2.98
Clinical-histopathological correlation of the abnormal retinal vessels in cerebral malaria. Arch Ophthalmol (2000) 2.97
Pathologic assessment of vasculopathies in pulmonary hypertension. J Am Coll Cardiol (2004) 2.93
Mixed messages: modulation of inflammation and immune responses by prostaglandins and thromboxanes. J Clin Invest (2001) 2.86
A human major histocompatibility complex class I gene that encodes a protein with a shortened cytoplasmic segment. Proc Natl Acad Sci U S A (1987) 2.77
Inhibition of angiogenesis decreases alveolarization in the developing rat lung. Am J Physiol Lung Cell Mol Physiol (2000) 2.73
The prostaglandin receptor EP4 triggers remodelling of the cardiovascular system at birth. Nature (1997) 2.56
Abolition of anaphylaxis by targeted disruption of the high affinity immunoglobulin E receptor alpha chain gene. Cell (1993) 2.54
Monoclonal endothelial cell proliferation is present in primary but not secondary pulmonary hypertension. J Clin Invest (1998) 2.54
Retracted BRCA1 required for transcription-coupled repair of oxidative DNA damage. Science (1998) 2.48
Disruption of the A(3) adenosine receptor gene in mice and its effect on stimulated inflammatory cells. J Biol Chem (2000) 2.44
Cloning and complete sequence of an HLA-A2 gene: analysis of two HLA-A alleles at the nucleotide level. J Immunol (1985) 2.43
Update of Clostridium difficile infection due to PCR ribotype 027 in Europe, 2008. Euro Surveill (2008) 2.43
Beta 2-microglobulin-, CD8+ T-cell-deficient mice survive inoculation with high doses of vaccinia virus and exhibit altered IgG responses. Proc Natl Acad Sci U S A (1992) 2.37
Plasma and lipids from stored packed red blood cells cause acute lung injury in an animal model. J Clin Invest (1998) 2.37
Defective epithelial chloride transport in a gene-targeted mouse model of cystic fibrosis. Science (1992) 2.36
Four country healthcare associated infection prevalence survey 2006: overview of the results. J Hosp Infect (2008) 2.35
Linkage map of the human major histocompatibility complex including the tumor necrosis factor genes. Proc Natl Acad Sci U S A (1987) 2.31
A novel receptor tyrosine kinase, Mer, inhibits TNF-alpha production and lipopolysaccharide-induced endotoxic shock. J Immunol (1999) 2.26
Decreased platelet aggregation, increased bleeding time and resistance to thromboembolism in P2Y1-deficient mice. Nat Med (1999) 2.25
Transfer and expression of three cloned human non-HLA-A,B,C class I major histocompatibility complex genes in mutant lymphoblastoid cells. Proc Natl Acad Sci U S A (1988) 2.12
Gene expression patterns in the lungs of patients with primary pulmonary hypertension: a gene microarray analysis. Circ Res (2001) 2.00
Receptors for prostaglandin E(2) that regulate cellular immune responses in the mouse. J Clin Invest (2001) 1.99
A STUDY OF RICKETTSIAE GROWN ON AGAR TISSUE CULTURES. J Exp Med (1939) 1.96
Isolation of HLA locus-specific DNA probes from the 3'-untranslated region. Proc Natl Acad Sci U S A (1984) 1.93
Secular trends in nosocomial bloodstream infections: antibiotic-resistant bacteria increase the total burden of infection. Clin Infect Dis (2012) 1.79
Microsatellite instability of endothelial cell growth and apoptosis genes within plexiform lesions in primary pulmonary hypertension. Circ Res (2001) 1.75
Reproductive failure and reduced blood pressure in mice lacking the EP2 prostaglandin E2 receptor. J Clin Invest (1999) 1.66
Three-dimensional reconstruction of pulmonary arteries in plexiform pulmonary hypertension using cell-specific markers. Evidence for a dynamic and heterogeneous process of pulmonary endothelial cell growth. Am J Pathol (1999) 1.63
Pulmonary prostacyclin synthase overexpression in transgenic mice protects against development of hypoxic pulmonary hypertension. J Clin Invest (1999) 1.59
Altered inflammatory responses in leukotriene-deficient mice. Proc Natl Acad Sci U S A (1994) 1.59
Failure of ductus arteriosus closure and remodeling in neonatal mice deficient in cyclooxygenase-1 and cyclooxygenase-2. Proc Natl Acad Sci U S A (2001) 1.58
Primary pulmonary hypertension between inflammation and cancer. Chest (1998) 1.57
In vitro release of vascular endothelial growth factor during platelet aggregation. Am J Physiol (1998) 1.54
Regulatory elements in the introns of the human HPRT gene are necessary for its expression in embryonic stem cells. Proc Natl Acad Sci U S A (1990) 1.53
Diffuse panbronchiolitis in the United States. Am J Respir Crit Care Med (1996) 1.53
Altered proliferative response by T lymphocytes of Ly-6A (Sca-1) null mice. J Exp Med (1997) 1.53
Nucleotide-regulated calcium signaling in lung fibroblasts and epithelial cells from normal and P2Y(2) receptor (-/-) mice. J Biol Chem (1999) 1.51
Agarose infiltration improves morphology of cryostat sections of lung. Lab Invest (1994) 1.51
Growth retardation, DNA repair defects, and lack of spermatogenesis in BRCA1-deficient mice. Mol Cell Biol (1999) 1.50
Coagulation defects and altered hemodynamic responses in mice lacking receptors for thromboxane A2. J Clin Invest (1998) 1.46
Pathogenesis and evolution of plexiform lesions in pulmonary hypertension associated with scleroderma and human immunodeficiency virus infection. Hum Pathol (1997) 1.46
Adenosine and inosine increase cutaneous vasopermeability by activating A(3) receptors on mast cells. J Clin Invest (2000) 1.40
Hypoxia-induced pulmonary vascular remodeling: a model for what human disease? J Clin Invest (2000) 1.39
Effect of loss of P2Y(2) receptor gene expression on nucleotide regulation of murine epithelial Cl(-) transport. J Biol Chem (1999) 1.39
Therapeutic drug monitoring of vancomycin in patients receiving haemodialysis: time for a change. J Clin Pathol (2006) 1.38
Allergy-associated FcRbeta is a molecular amplifier of IgE- and IgG-mediated in vivo responses. Immunity (1998) 1.36
Sex steroids, glucocorticoids, stress and autoimmunity. J Steroid Biochem Mol Biol (1991) 1.34
Human leukocyte antigen F (HLA-F). An expressed HLA gene composed of a class I coding sequence linked to a novel transcribed repetitive element. J Exp Med (1990) 1.33
Identification of specific EP receptors responsible for the hemodynamic effects of PGE2. Am J Physiol (1999) 1.33
HOX genes in human lung: altered expression in primary pulmonary hypertension and emphysema. Am J Pathol (2001) 1.29
Activation of the murine EP3 receptor for PGE2 inhibits cAMP production and promotes platelet aggregation. J Clin Invest (2001) 1.29
Apoptosis in the lung: induction, clearance and detection. Am J Physiol Lung Cell Mol Physiol (2008) 1.29
Collagen-induced arthritis is reduced in 5-lipoxygenase-activating protein-deficient mice. J Exp Med (1997) 1.29
Mammary tumor formation in p53- and BRCA1-deficient mice. Cell Growth Differ (1999) 1.28
HIV associated pulmonary emphysema: a review of the literature and inquiry into its mechanism. Thorax (2008) 1.26
A new embryonic stem cell line from DBA/1lacJ mice allows genetic modification in a murine model of human inflammation. Exp Cell Res (1995) 1.26
Determination of the contribution of cysteinyl leukotrienes and leukotriene B4 in acute inflammatory responses using 5-lipoxygenase- and leukotriene A4 hydrolase-deficient mice. J Immunol (1999) 1.26
Genetic and phenotypic analysis of biofilm phenotypic variation in multiple Staphylococcus epidermidis isolates. J Med Microbiol (2004) 1.25
The HLA class I gene family includes at least six genes and twelve pseudogenes and gene fragments. J Immunol (1992) 1.25
Neutrophils are major contributors to intraparenchymal lung IL-1 beta expression after hemorrhage and endotoxemia. J Immunol (1998) 1.21
Cardiovascular responses to the isoprostanes iPF(2alpha)-III and iPE(2)-III are mediated via the thromboxane A(2) receptor in vivo. Circulation (2000) 1.21
Role of the 5-lipoxygenase-activating protein (FLAP) in murine acute inflammatory responses. J Exp Med (1997) 1.19
Metabolism of leukotriene A4 by human erythrocytes. A novel cellular source of leukotriene B4. J Biol Chem (1984) 1.18
Minimally invasive repair of pectus excavatum: a single institution's experience. Surgery (2001) 1.18
Interleukin-1 receptor antagonist treatment reduces pulmonary hypertension generated in rats by monocrotaline. Am J Respir Cell Mol Biol (1994) 1.18
5-Lipoxygenase and 5-lipoxygenase activating protein (FLAP) immunoreactivity in lungs from patients with primary pulmonary hypertension. Am J Respir Crit Care Med (1998) 1.18
A calcium-activated protease possibly involved in myofibrillar protein turnover. Isolation of a low-calcium-requiring form of the protease. Biochim Biophys Acta (1981) 1.18
Anaphylaxis mediated through a humanized high affinity IgE receptor. J Immunol (1996) 1.18
Failure of spermatogenesis in mouse lines deficient in the Na(+)-K(+)-2Cl(-) cotransporter. J Clin Invest (2000) 1.17
Cellular and molecular mechanisms in the pathogenesis of severe pulmonary hypertension. Eur Respir J (1995) 1.17
Urinary concentrating function in mice lacking EP3 receptors for prostaglandin E2. Am J Physiol (1998) 1.16
Obliterative bronchiolitis: varying presentations and clinicopathological correlation. Eur Respir J (2002) 1.16
Prostaglandins induce vascular endothelial growth factor in a human monocytic cell line and rat lungs via cAMP. Am J Respir Cell Mol Biol (1997) 1.13
Reduced IL-4-, lipopolysaccharide-, and IFN-gamma-induced MHC class II expression in mice lacking class II transactivator due to targeted deletion of the GTP-binding domain. J Immunol (1999) 1.10
Chronic intrauterine pulmonary hypertension impairs endothelial nitric oxide synthase in the ovine fetus. Am J Physiol (1997) 1.10
The relationship of chronic mucin secretion to airway disease in normal and CFTR-deficient mice. Am J Respir Cell Mol Biol (1998) 1.09
Death and the maiden. Sci Justice (2001) 1.08
Enzymatic hydration of leukotriene A4. Purification and characterization of a novel epoxide hydrolase from human erythrocytes. J Biol Chem (1985) 1.08
Mechanisms of platelet-activating factor-induced lipid body formation: requisite roles for 5-lipoxygenase and de novo protein synthesis in the compartmentalization of neutrophil lipids. J Exp Med (1996) 1.07
Impact of ionizing radiation and genetic background on mammary tumorigenesis in p53-deficient mice. Cancer Res (2001) 1.06
Prolonged endothelin A receptor blockade attenuates chronic pulmonary hypertension in the ovine fetus. J Clin Invest (1997) 1.05
Endotoxin after gut ischemia/reperfusion causes irreversible lung injury. J Surg Res (1992) 1.03